Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BBIO
EXEL
Add up to 3 more stocks
BBIO
BridgeBio Pharma, Inc.
+0.86%
$66.71+0.57Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$13.07B
52W Range
$52.75 - $93.42
EXEL
Exelixis, Inc.
-1.12%
$58.19-0.66Delayed quote: Oct 6, 2026, 3:30 PM EDT
Market Cap
$14.63B
52W Range
$33.76 - $61.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 18.24 |
| Forward P/E | N/A | 16.57 |
| PEG Ratio | N/A | 0.36 |
| P/B Ratio | N/A | 7.93 |
| P/S Ratio | 18.32 | 6.00 |
| P/FCF Ratio | N/A | 12.63 |
| EV/EBITDA | N/A | 14.51 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 93.3% | 96.5% |
| Operating Margin | -113.3% | 39.9% |
| Net Margin | -97.6% | 35.3% |
| ROE | N/A | 46.7% |
| ROA | -57.2% | 34.5% |
| ROIC | -62.1% | 37.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.23 | 3.46 |
| Quick Ratio | 1.17 | 3.38 |
| Debt/Equity | N/A | 0.09 |
| Interest Coverage | -10.72 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.